Since 1997, human infection with avian H5N1, having about 60% mortality, has posed a threat to public health. In this review, we describe the epidemiology of H5N1 transmission, advantages and disadvantages of different influenza vaccine types, and characteristics of adenovirus, finally summarizing advances in adenovirus-based H5N1 systemic and mucosal vaccines.
Keywords: Adenovirus; H5N1; Mucosal; Vaccine.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.